Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica

Clinical trial NCT07286214 · RECRUITING

Trial details

NCT number: NCT07286214
Sponsor: Sanofi
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Polymyalgia Rheumatica

Start date: 2026-05-12
Primary completion: 2029-06-04
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.